Enoyl-acyl carrier protein reductase explained
| Enoyl-acyl carrier protein reductase |
| Ec Number: | 1.3.1.9 |
| Cas Number: | 37251-08-4 |
| Go Code: | 0016631 |
| Width: | 270 |
Enoyl-acyl carrier protein reductase (or ENR), is a key enzyme of the type II fatty acid synthesis (FAS) system.[1] ENR is an attractive target for narrow-spectrum antibacterial drug discovery because of its essential role in metabolism and its sequence conservation across many bacterial species. In addition, the bacterial ENR sequence and structural organization are distinctly different from those of mammalian fatty acid biosynthesis enzymes.[2]
At lower concentrations, Triclosan and Triclocarban provide a bacteriostatic effect by binding to ENR. Atromentin and leucomelone possess antibacterial activity, inhibiting the enzyme in the bacteria Streptococcus pneumoniae.[3]
See also
Notes and References
- Kapoor M, Gopalakrishnapai J, Surolia N, Surolia A . Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum . The Biochemical Journal . 381 . Pt 3 . 735–41 . August 2004 . 15139852 . 1133883 . 10.1042/BJ20040302 .
- Ling LL, Xian J, Ali S, Geng B, Fan J, Mills DM, Arvanites AC, Orgueira H, Ashwell MA, Carmel G, Xiang Y, Moir DT . Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductase . Antimicrobial Agents and Chemotherapy . 48 . 5 . 1541–7 . May 2004 . 15105103 . 400533 . 10.1128/aac.48.5.1541-1547.2004.
- Zheng CJ, Sohn MJ, Kim WG . Atromentin and leucomelone, the first inhibitors specific to enoyl-ACP reductase (FabK) of Streptococcus pneumoniae . The Journal of Antibiotics . 59 . 12 . 808–12 . December 2006 . 17323650 . 10.1038/ja.2006.108 . free .
